Unpacking sources of transmission in HIV prevention trials with deep-sequence pathogen data -- BCPP/ Ya Tsie study
Magosi, L. E.; Tchetgen Tchetgen, E. J.; Novitsky, V.; Pretorius Holme, M.; Moore, J.; Bachanas, P.; Lebelonyane, R.; Fraser, C.; Moyo, S.; Hurwitz, K. E.; Gaolathe, T.; Goyal, R.; Makhema, J.; Lockman, S.; Essex, M.; De Gruttola, V.; Lipsitch, M. E.
Show abstract
To develop effective HIV prevention strategies that can guide public health policy it is important to identify the main sources of infection in HIV prevention studies. Accordingly, we devised a statistical approach that leverages deep- (or next generation) sequenced pathogen data to estimate the relative contribution of different sources of infection in community-randomized trials of infectious disease prevention. We applied this approach to the Botswana Combination Prevention Project (BCPP) and estimated that 90% [95% Confidence Interval (CI): 81 - 93] of new infections that occurred in individuals in communities that received combination prevention (including universal HIV test-and-treat) originated from individuals residing in communities outside of the trial area. We estimate that the relative impact of the intervention was greater in rural geographically isolated communities with limited opportunity for imported infections compared to communities neighboring major urban centers. Treating people with HIV limits the spread of infection to uninfected individuals; accordingly, counterfactual modeling scenarios estimated that a nationwide application of the intervention could have reduced transmissions to recipients in trial communities by 59% [3 - 87], much higher than the observed 30% reduction. Our results suggest that the impact of the BCPP trial intervention was substantially limited by sources of transmission outside the trial area, and that the impact of the intervention could be considerably larger if applied nationally. We recommend that studies of infectious disease prevention consider the impact of sources of transmission beyond the reach of the intervention when designing and evaluating interventions to inform public health programs.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Trends in HIV self-testing uptake in Africa: a modeling study of population-based surveys and HIV testing program data 93%
- The impact of geographic targeting of oral cholera vaccination in sub-Saharan Africa: a modeling study 92%
- Cost-effectiveness of screening with transcriptional signatures for incipient TB among U.S. migrants 90%
Similar papers in this journal
- Predicting HIV Incidence in the SEARCH Trial: A Mathematical Modelling Study 96%
- Maternal HIV retesting during pregnancy and postpartum among high-risk populations in Kenya, South Africa, and Ukraine: Cost-effectiveness of preventing vertical transmission 94%
- Population Impact and Efficiency of Improvements to HIV PrEP Under Conditions of High ART Coverage among San Francisco Men Who Have Sex with Men 93%
Similar papers in this journal
- A Moving Target: Impacts of Lowering Viral Load Suppression Cutpoints on Progress Towards HIV Epidemic Control Goals 95%
- Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size 94%
- National HIV testing and diagnosis coverage in sub-Saharan Africa: a new modeling tool for estimating the \"first 90\" from program and survey data 93%
Similar papers in this journal
- Single-dose effectiveness of mpox vaccine in Quebec, Canada: test-negative design with and without adjustment for self-reported exposure risk 93%
- Patterns of HIV-1 viral load suppression and drug resistance during the dolutegravir transition: a population-based longitudinal study 93%
- Household transmission of SARS-CoV-2 from adult index cases living with and without HIV in South Africa, 2020-2021: a case-ascertained, prospective observational household transmission study 93%
Similar papers in this journal
- Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial – BCPP/ Ya Tsie trial 98%
- Differences in HIV-1 reservoir size, landscape characteristics and decay dynamics in acute and chronic treated HIV-1 Clade C infection 94%
- Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels as compared with therapy based on protease inhibitors 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.